JeffreyAllanZonderMD
Hematology • Detroit, MIHematologic Oncology
Professor of Oncology (Multiple Myeloma and Amyloidosis Specialist)
Dr. Zonder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Karmanos Cancer Center
4100 John R Hwcrc 4th Fl
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767- Is this information wrong?
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
University of RochesterResidency, Internal Medicine, 1995 - 1998
Wayne State University School of MedicineClass of 1995
Duke UniversityBA, Biological Anthropology, Art-Design (Double Major), 1987 - 1991
Certifications & Licensure
MI State Medical License 1998 - 2026- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Accelerator Award Multiple Myeloma Research Foundation, 2015
- School of Medicine Teaching Award Wayne State University, 2005, 2012, 2015
- Fellows' Hematology Teaching Award Division of Hematology-Oncology, 2007, 2012
Clinical Trials
- Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia Start of enrollment: 2005 May 01
- Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma Start of enrollment: 2006 Dec 01
- Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.Xavier Leleu, Hans C Lee, Jeffrey A Zonder, Margaret Macro, Karthik Ramasamy, Cyrille Hulin, Jiri Silar, Matyas Kuhn, Kaili Ren, Nawal Bent-Ennakhil, Dasha Cherepanov,...> ;Future Oncology. 2024 May 1
- Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States.Tondre Buck, Monique A Hartley-Brown, Yvonne A Efebera, Carter P Milner, Jeffrey A Zonder, Paul G Richardson, Taylor Salinardi, Megan S Rice> ;Haematologica. 2023 Nov 30
- Inflammation of actinic keratosis from chemotherapy in a relapsed multiple myeloma patient.Abdul Moiz Khan, Tarec Micho Ulbeh, Jeffrey Zonder, Suresh Balasubramanian> ;BMJ Case Reports. 2023 Nov 21
- Join now to see all
Abstracts/Posters
- Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ...Jeffrey A. Zonder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma Who Have B...Jeffrey A. Zonder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: ...Jeffrey A. Zonder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Untangling Amyloidosis 201961st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Untangling Amyloidosis 201961st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) – Effectiveness in Routine Clinical Practice Is Similar to t...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
The Uncanny Symptoms That Led to a Detroit Filmmaker’s Multiple Myeloma DiagnosisMay 3rd, 2023- Triple-Drug Therapy for Post-Transplant Management of Multiple MyelomaJanuary 13th, 2023
- Expanded Cancer CareNovember 21st, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- International Society of AmyloidosisMember
Hospital Affiliations
DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan
Karmanos Cancer CenterDetroit, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
